Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jun 14, 2023

BUY
$20.69 - $20.91 $134,526 - $135,956
6,502 New
6,502 $136 Million
Q2 2022

Jun 20, 2023

BUY
$13.8 - $20.82 $89,727 - $135,371
6,502 New
6,502 $134,000
Q1 2022

Jun 20, 2023

BUY
$15.96 - $18.87 $103,771 - $122,692
6,502 New
6,502 $109,000
Q1 2022

Mar 30, 2023

SELL
$15.96 - $18.87 $308,730 - $365,021
-19,344 Reduced 74.84%
6,502 $109,000
Q1 2022

May 12, 2022

SELL
$15.96 - $18.87 $308,730 - $365,021
-19,344 Reduced 74.84%
6,502 $109,000
Q4 2021

Jun 21, 2023

BUY
$16.79 - $20.37 $433,954 - $526,483
25,846 New
25,846 $516,000
Q3 2021

Jun 21, 2023

BUY
$18.14 - $27.03 $468,846 - $698,617
25,846 New
25,846 $468,000
Q3 2021

Mar 30, 2023

SELL
$18.14 - $27.03 $41,903 - $62,439
-2,310 Reduced 8.2%
25,846 $468,000
Q3 2021

Nov 15, 2021

SELL
$18.14 - $27.03 $41,903 - $62,439
-2,310 Reduced 8.2%
25,846 $469,000
Q2 2021

Jun 21, 2023

BUY
$25.24 - $30.86 $710,657 - $868,894
28,156 New
28,156 $760,000
Q2 2021

Mar 30, 2023

SELL
$25.24 - $30.86 $77,158 - $94,339
-3,057 Reduced 9.79%
28,156 $760,000
Q2 2021

Aug 16, 2021

BUY
$25.24 - $30.86 $709,875 - $867,937
28,125 Added 90725.81%
28,156 $760,000
Q1 2021

Jun 26, 2023

BUY
$28.29 - $39.89 $883,015 - $1.25 Million
31,213 New
31,213 $935 Million
Q1 2021

Mar 30, 2023

SELL
$28.29 - $39.89 $34,400 - $48,506
-1,216 Reduced 3.75%
31,213 $935,000
Q1 2021

May 14, 2021

SELL
$28.29 - $39.89 $916,539 - $1.29 Million
-32,398 Reduced 99.9%
31 $935,000
Q4 2020

Jun 22, 2023

BUY
$24.45 - $31.59 $792,889 - $1.02 Million
32,429 New
32,429 $932,000
Q4 2020

Mar 30, 2023

BUY
$24.45 - $31.59 $74,719 - $96,539
3,056 Added 10.4%
32,429 $932,000
Q4 2020

Feb 16, 2021

BUY
$24.45 - $31.59 $74,719 - $96,539
3,056 Added 10.4%
32,429 $932,000
Q3 2020

Jun 26, 2023

BUY
$17.22 - $24.59 $505,803 - $722,282
29,373 New
29,373 $716,000
Q3 2020

Mar 30, 2023

SELL
$17.22 - $24.59 $10,332 - $14,754
-600 Reduced 2.0%
29,373 $716,000
Q3 2020

Nov 13, 2020

SELL
$17.22 - $24.59 $10,332 - $14,754
-600 Reduced 2.0%
29,373 $717,000
Q2 2020

Jun 26, 2023

BUY
$6.46 - $19.27 $193,625 - $577,579
29,973 New
29,973 $536,000
Q2 2020

Mar 30, 2023

BUY
$6.46 - $19.27 $178,444 - $532,295
27,623 Added 1175.45%
29,973 $536,000
Q2 2020

Aug 14, 2020

BUY
$6.46 - $19.27 $178,444 - $532,295
27,623 Added 1175.45%
29,973 $536,000
Q1 2020

Jul 12, 2023

BUY
$5.64 - $15.23 $13,254 - $35,790
2,350 New
2,350 $19,000
Q1 2020

Mar 30, 2023

BUY
$5.64 - $15.23 $5 - $15
1 Added 0.04%
2,350 $19,000
Q1 2020

May 15, 2020

BUY
$5.64 - $15.23 $5 - $15
1 Added 0.04%
2,350 $19,000
Q4 2019

Jul 12, 2023

BUY
$8.8 - $14.93 $20,671 - $35,070
2,349 New
2,349 $31,000
Q4 2019

Mar 30, 2023

SELL
$8.8 - $14.93 $218,451 - $370,622
-24,824 Reduced 91.36%
2,349 $31,000
Q4 2019

Feb 14, 2020

SELL
$8.8 - $14.93 $218,451 - $370,622
-24,824 Reduced 91.36%
2,349 $31,000
Q3 2019

Jul 12, 2023

BUY
$11.76 - $25.57 $319,554 - $694,813
27,173 New
27,173 $323,000
Q3 2019

Mar 30, 2023

BUY
$11.76 - $25.57 $1,481 - $3,221
126 Added 0.47%
27,173 $323,000
Q3 2019

Nov 14, 2019

BUY
$11.76 - $25.57 $1,481 - $3,221
126 Added 0.47%
27,173 $323,000
Q2 2019

Jul 12, 2023

BUY
$22.88 - $33.27 $618,835 - $899,853
27,047 New
27,047 $661,000
Q2 2019

Mar 30, 2023

BUY
$22.88 - $33.27 $2,402 - $3,493
105 Added 0.39%
27,047 $661,000
Q2 2019

Aug 14, 2019

BUY
$22.88 - $33.27 $2,402 - $3,493
105 Added 0.39%
27,047 $662,000
Q1 2019

Jul 13, 2023

BUY
$31.52 - $46.19 $849,211 - $1.24 Million
26,942 New
26,942 $858,000
Q1 2019

Mar 30, 2023

BUY
$31.52 - $46.19 $849,211 - $1.24 Million
26,942 New
26,942 $858,000
Q1 2019

May 16, 2019

BUY
$31.52 - $46.19 $399,200 - $584,996
12,665 Added 88.71%
26,942 $858,000
Q1 2019

May 15, 2019

BUY
$31.52 - $46.19 $450,011 - $659,454
14,277 New
14,277 $312,000

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.